Comprehensive Disease Analysis

Unlocking the Power of Omics Data

Despite the explosion of omics data, the industry continues to rely on single point mutations to guide decisions.

InnoSIGN changes that.

Our platform transforms complex multi-omics data into actionable, easy-to-interpret insights—powered by a proprietary algorithm that identifies the true driver of the disease. This accelerates drug discovery and improves treatment selection.

Our disease interpretation platform is universally applicable.

Across many diseases, our platform delivers a locked design ideally suited to support the full drug development continuum—from preclinical to CDx to commercial launch.